Claritev Corporation (Class A) (CTEV) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

Per the Roarable RQD rating, CTEV scores 23 out of 100 and receives a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are:

• Fundamental Cash Engine: 8 / 20. Per the RQD rating, ROIC is 85% while FCF yield is -3.02%. A very high ROIC alongside negative free cash flow yield signals that reported returns are not converting into distributable cash, which weakens confidence in the earnings base.
• Whale 13F Flow: 5 / 20. The RQD pillar label references institutional accumulation and options positioning. No holder-level detail is provided in the source data, so the score can be noted but not independently traced.
• Insider Conviction: 4 / 20. The RQD pillar label references SEC Form 4 and Congressional PTR cluster flow. Specific transactions are not itemized in the holders section (see Analyst View).
• Macro Regime Fit: 4 / 20. Per the RQD rating, beta is 1.0 and the score reflects sector sensitivity. A beta of 1.0 means the stock is assessed as moving in line with the broader market, offering no defensive cushion.
• Forensic Balance Sheet: 2 / 20. Per the RQD rating, Altman Z is 0.2, Piotroski F is 3/9, and Debt/Equity is 0.5. This is the weakest pillar and the primary driver of the forensic-risk classification.

For a prospective investor evaluating the stock today, the upside case rests almost entirely on the 85% ROIC figure and a 4.35% one-day price move. The valuation tradeoff is stark: EV/EBITDA of 2.8 appears low in isolation, but it sits alongside negative net margin, negative FCF yield, and a 52-week range from $11.5 to $73.68, indicating extreme price volatility. The RQD verdict treats these combined signals as a forensic-risk profile rather than a value opportunity.

Per the SEC financials, operating income swung from $162.0M in FY 2023 to $-1389.9M in FY 2024 and returned to $28.8M in FY 2025, while net income was negative in all three periods. Per the Snapshot data, the net margin is -29.4% and the operating margin is 3%. Per the RQD rating, the Altman Z-Score is 0.2 and the Piotroski F-Score is 3/9, both in forensic-risk territory. Per the RQD rating, Debt/Equity is 0.5; the source data does not report total debt values in the financials table.

Per the recent news and catalysts section, five items were reported, each tagged to CTEV:

• Yahoo! Finance Canada, Yahoo Finance UK, and TradingView coverage was classified as YELLOW / MARKET WIRE, describing general market action and institutional positioning without specific new facts.
• A Stock Titan item reported that an officer proposed selling CTEV shares valued at about $139K, classified YELLOW / MARKET WIRE.
• A Yahoo Finance item headlined a 5.2% surge, classified GREEN / CATALYST, the only item in the set with a positive light signal.
• A TradingView item referencing Tempus AI was classified YELLOW / MARKET WIRE.

Per the Butterfly Supply-Chain Graph, supply chain status is NONE, with no butterfly links and no proprietary signals recorded.

Per the Butterfly Supply-Chain Graph, no upstream or downstream dependencies, butterfly links, or proprietary signals are recorded for CTEV. Sector correlations, bottlenecks, and second-order ripples cannot be mapped from the source data. A prospective investor should note that the sector and industry classifications alone do not establish any dependency chain.

• What drove the operating loss of $-1389.9M in FY 2024 and the subsequent recovery to $28.8M in FY 2025, and is the FY 2025 operating result sustainable?
• What are total debt and EPS values, given that both are reported as N/A in the financials table while Debt/Equity is cited at 0.5?
• What explains the gap between an 85% ROIC and a -3.02% FCF yield, and how is ROIC being calculated?
• What are the specific holder positions, 13F filings, and insider transactions behind the whale and insider pillar scores?
• What was the nature of the officer's proposed share sale, and does it represent routine activity or a signal?